PRECIPIO, INC. Cash and Restricted Cash
PRECIPIO, INC. (PRPO) had Cash and Restricted Cash of $3.08 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.08M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.60M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.65M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.31M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $3.08M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $2.60M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $2.65M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $2.31M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $1.13M 10-Q · filed 2026-08-14 |
| 2025-03-31 | $1.02M 10-Q · filed 2026-05-14 |
| 2024-12-31 | $1.39M 10-Q · filed 2026-08-14 |
| 2024-09-30 | $1.05M 10-Q · filed 2025-11-14 |
| 2024-06-30 | $1.28M 10-Q · filed 2025-08-13 |
| 2024-03-31 | $776.00K 10-Q · filed 2025-05-14 |
| 2023-12-31 | $1.50M 10-K · filed 2026-03-30 |
| 2023-09-30 | $1.56M 10-Q · filed 2024-11-06 |
| 2023-06-30 | $2.57M 10-Q · filed 2024-08-13 |
| 2023-03-31 | $2.14M 10-Q · filed 2024-05-14 |
| 2022-12-31 | $3.44M 10-K · filed 2025-03-27 |
| 2022-09-30 | $5.14M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $7.47M 10-Q · filed 2023-08-11 |
| 2022-03-31 | $9.26M 10-Q · filed 2023-05-12 |
| 2021-12-31 | $11.67M 10-K · filed 2024-03-29 |
| 2021-09-30 | $13.22M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $15.70M 10-Q · filed 2022-08-11 |
| 2021-03-31 | $2.29M 10-Q · filed 2022-05-11 |
| 2020-12-31 | $2.66M 10-K · filed 2023-03-30 |
| 2020-09-30 | $2.16M 10-Q · filed 2021-11-12 |
| 2020-06-30 | $353.00K 10-Q · filed 2021-08-12 |
| 2020-03-31 | $417.00K 10-Q · filed 2021-05-14 |
| 2019-12-31 | $848.00K 10-K · filed 2022-03-30 |
| 2019-09-30 | $1.68M 10-Q · filed 2020-11-13 |
| 2019-06-30 | $1.17M 10-Q · filed 2020-08-13 |
| 2019-03-31 | $302.00K 10-Q · filed 2020-05-14 |
| 2018-12-31 | $381.00K 10-K · filed 2021-03-29 |
| 2018-09-30 | $219.00K 10-Q · filed 2019-11-13 |
| 2018-06-30 | $71.00K 10-Q · filed 2019-08-09 |
| 2017-12-31 | $421.00K 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |